Now that their role in vaccine research is over, 117 chimpanzees in Japan
face an uncertain fate. The chimps were imported in 1975 for a hepatitis B
vaccine programme and are now in a holding facility run by the drug company
Sanwa Kagaku. The company says it can no longer afford the annual £1.5
million upkeep. There are only a few comparable chimp facilities in the world,
and all are government-subsidised. But the Japanese government is reluctant to
take responsibility for the chimps.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
91É«ÇéƬ
I’m the first person whose life was saved by CRISPR base editing
News
Technology
US government wants to have a useful quantum computer by 2028
News
Life
Childbirth for many primate species is even harder than for humans
News
Humans
Humans sleep the least of all apes – is it the secret to our success?
Features
Popular articles
Trending New Scientist articles
1
Where, when and how to watch the 2026 solar eclipse
2
Humans sleep the least of all apes – is it the secret to our success?
3
If you aren't terrified by this heatwave, you should be
4
We’ve uncovered a master gene that switches on human development
5
US government wants to have a useful quantum computer by 2028
6
Our verdict on The Selfish Gene: An unpopular piece of popular science
7
Remote-controlled cockroach swarm can now breathe underwater
8
Fully autonomous drones have killed human soldiers for the first time
9
Read an extract from Slow Gods by Claire North
10
The best sci-fi novel in 2026 so far – plus 6 other great reads
